MetLife Investment Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153K Hold
9,652
﹤0.01% 2348
2025
Q4
$171K Hold
9,652
﹤0.01% 2351
2025
Q3
$179K Hold
9,652
﹤0.01% 2380
2025
Q2
$207K Hold
9,652
﹤0.01% 2169
2025
Q1
$238K Sell
9,652
-311
-3% -$7.68K ﹤0.01% 2111
2024
Q4
$231K Hold
9,963
﹤0.01% 2233
2024
Q3
$270K Hold
9,963
﹤0.01% 2137
2024
Q2
$287K Buy
9,963
+1,044
+12% +$32K ﹤0.01% 2028
2024
Q1
$260K Hold
8,919
﹤0.01% 2051
2023
Q4
$290K Hold
8,919
﹤0.01% 2024
2023
Q3
$285K Hold
8,919
﹤0.01% 1986
2023
Q2
$391K Buy
8,919
+499
+6% +$23K ﹤0.01% 1861
2023
Q1
$373K Hold
8,420
﹤0.01% 1828
2022
Q4
$335K Hold
8,420
﹤0.01% 1901
2022
Q3
$388K Hold
8,420
﹤0.01% 1819
2022
Q2
$363K Hold
8,420
﹤0.01% 1882
2022
Q1
$455K Buy
8,420
+2,803
+50% +$143K ﹤0.01% 1832
2021
Q4
$336K Hold
5,617
﹤0.01% 1732
2021
Q3
$368K Hold
5,617
﹤0.01% 1707
2021
Q2
$355K Hold
5,617
﹤0.01% 1785
2021
Q1
$274K Hold
5,617
﹤0.01% 1872
2020
Q4
$232K Hold
5,617
﹤0.01% 1902
2020
Q3
$258K Hold
5,617
﹤0.01% 1704
2020
Q2
$246K Buy
5,617
+1,009
+22% +$45.4K ﹤0.01% 1778
2020
Q1
$183K Buy
4,608
+932
+25% +$41.8K ﹤0.01% 1749
2019
Q4
$173K Hold
3,676
﹤0.01% 2055
2019
Q3
$130K Hold
3,676
﹤0.01% 2189
2019
Q2
$143K Hold
3,676
﹤0.01% 2213
2019
Q1
$163K Hold
3,676
﹤0.01% 2085
2018
Q4
$128K Buy
+3,676
New +$116K ﹤0.01% 2167

Other funds holding KIDS

MetLife Investment Management's KIDS Position: Q1 2026 in Review

MetLife Investment Management held its OrthoPediatrics (KIDS) position steady in Q1 2026 at 9,652 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

MetLife Investment Management first reported a position in KIDS in Q4 2018 and has held it in 30 quarters since. The position peaked at $455K in Q1 2022. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • MetLife Investment Management held 9,652 shares of OrthoPediatrics worth $153K as of Q1 2026.
  • MetLife Investment Management left its OrthoPediatrics share count unchanged in Q1 2026.
  • OrthoPediatrics made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2348 holding.
  • MetLife Investment Management first reported a position in OrthoPediatrics in Q4 2018 and has held it in 30 quarters since.
  • MetLife Investment Management's OrthoPediatrics position peaked at $455K in Q1 2022.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.